88 related articles for article (PubMed ID: 8402473)
1. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of advanced gastric cancer.
Suzuki T; Ochiai T; Nagata M; Koide Y; Gunji Y; Nakajima K; Yokoyama T; Kashiwabara H; Isono K
Cancer; 1993 Nov; 72(9):2537-42. PubMed ID: 8402473
[TBL] [Abstract][Full Text] [Related]
2. [Effect of high dose etoposide, adriamycin, cisplatin (EAP) therapy with autologous bone marrow transplantation in gastric cancer].
Suzuki T; Ochiai T; Ozaki M; Asano T; Koide Y; Gunji Y; Shu S; Hori S; Nabeya Y; Isono K
Gan To Kagaku Ryoho; 1990 May; 17(5):1069-72. PubMed ID: 2334173
[TBL] [Abstract][Full Text] [Related]
3. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
Haim N; Tsalik M; Robinson E
Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
[TBL] [Abstract][Full Text] [Related]
4. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.
Nichols CR; Andersen J; Lazarus HM; Fisher H; Greer J; Stadtmauer EA; Loehrer PJ; Trump DL
J Clin Oncol; 1992 Apr; 10(4):558-63. PubMed ID: 1312584
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.
Ueda Y; Sonoda Y; Fujiki H; Harada S; Kimura T; Itoh T; Imura K; Naito K; Nomura K; Taniwaki M; Yamagishi H
Oncol Rep; 2004 Aug; 12(2):323-32. PubMed ID: 15254697
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma.
Meisenberg BR; Ross M; Vredenburgh JJ; Jones R; Shpall EJ; Seigler HF; Coniglio DM; Wu K; Peters WP
J Natl Cancer Inst; 1993 Jul; 85(13):1080-5. PubMed ID: 8515495
[TBL] [Abstract][Full Text] [Related]
8. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
[TBL] [Abstract][Full Text] [Related]
9. Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
Broun ER; Nichols CR; Mandanas R; Salzman D; Turns M; Hromas R; Cornetta K; Einhorn LH
Bone Marrow Transplant; 1995 Sep; 16(3):353-8. PubMed ID: 8535306
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
11. High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
Spitzer G; Farha P; Valdivieso M; Dicke K; Zander A; Vellekoop L; Murphy WK; Dhingra HM; Umsawasdi T; Chiuten D
J Clin Oncol; 1986 Jan; 4(1):4-13. PubMed ID: 3510281
[TBL] [Abstract][Full Text] [Related]
12. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
13. [Role of autologous bone marrow transplantation in cancer chemotherapy].
Tajima T; Tokuda Y; Kubota M; Ohta M; Yokoyama S; Mitomi T; Nakamura Y; Watanabe K; Murakami M; Shinozuka T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3018-24. PubMed ID: 3056274
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
[TBL] [Abstract][Full Text] [Related]
15. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
Lotz JP; Bouleuc C; André T; Touboul E; Macovei C; Hannoun L; Lefranc JP; Houry S; Uzan S; Izrael V
Cancer; 1996 Jun; 77(12):2550-9. PubMed ID: 8640705
[TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation.
Ghalie R; Richman CM; Adler SS; Cobleigh MA; Korenblit AD; Manson SD; McLeod BC; Taylor SG; Valentino LA; Wolter J
J Clin Oncol; 1994 Feb; 12(2):342-6. PubMed ID: 8113841
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
[TBL] [Abstract][Full Text] [Related]
18. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN
J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687
[TBL] [Abstract][Full Text] [Related]
19. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Sniecinski I
Cancer; 1994 Jan; 73(1):125-34. PubMed ID: 7903906
[TBL] [Abstract][Full Text] [Related]
20. High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study.
Saez RA; Slease RB; Strnad C; Selby GB; Confer DL; Epstein RB
Bone Marrow Transplant; 1995 Oct; 16(4):507-14. PubMed ID: 8528165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
